Accordingly, a reduced rate of MM cell proliferation paralleled by a reduced FGFR1 activation occurred in vivo in both endothelial and tumor cells when PTX3 was overexpressed and accumulated in the extracellular matrix of grafted tumors. This evidence concerns the gene PTX3 and neoplasm.